Next-generation immunotherapy for pancreatic ductal adenocarcinoma: navigating pathways of immune resistance
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
https://link.springer.com/content/pdf/10.1007/s10555-021-09981-3.pdf
Reference219 articles.
1. Rahib, L., Wehner, M. R., Matrisian, L. M., & Nead, K. T. (2021). Estimated projection of US cancer incidence and death to 2040. JAMA Network Open, 4(4), e214708. https://doi.org/10.1001/jamanetworkopen.2021.4708 Accessed 4/11/2021.
2. Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394–424. https://onlinelibrary.wiley.com/doi/abs/10.3322/caac.21492. https://doi.org/10.3322/caac.21492.
3. Sohal, D.P.S., Kennedy, E.B., Cinar, P., et al., (2020) Metastatic pancreatic cancer: ASCO guideline Update, Jco, JCO.20.01364. https://doi.org/10.1200/JCO.20.01364.
4. Conroy, T., Desseigne, F., Ychou, M., et al. (2011). FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. The New England Journal of Medicine., 364(19), 1817–1825. https://search.datacite.org/works/10.1056/nejmoa1011923. https://doi.org/10.1056/nejmoa1011923.
5. Von Hoff, D. D., Ervin, T., Arena, F. P., et al. (2013). Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. The New England Journal of Medicine., 369(18), 1691–1703. https://doi.org/10.1056/NEJMoa1304369.
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Current and future immunotherapeutic approaches in pancreatic cancer treatment;Journal of Hematology & Oncology;2024-06-04
2. Treatment resistance in pancreatic and biliary tract cancer: molecular and clinical pharmacology perspectives;Expert Review of Clinical Pharmacology;2024-03-15
3. Clinical Impact of Preoperative Biliary Drainage in Patients with Ductal Adenocarcinoma of the Pancreatic Head;Diagnostics;2023-03-28
4. Combination immunotherapy for pancreatic cancer: challenges and future considerations;Expert Review of Clinical Immunology;2022-09-11
5. Pancreatic Cancer: Pathogenesis, Screening, Diagnosis, and Treatment;Gastroenterology;2022-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3